Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis

[1]  A. Hofman,et al.  Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study , 2016, Hepatology.

[2]  E. Bjornsson,et al.  Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. , 2015, Gastroenterology.

[3]  A. Burt,et al.  Diagnosis and Assessment of NAFLD: Definitions and Histopathological Classification , 2015, Seminars in Liver Disease.

[4]  P. O’Rourke,et al.  ELF score ≥9.8 indicates advanced hepatic fibrosis and is influenced by age, steatosis and histological activity , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[5]  E. Bugianesi,et al.  The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[6]  A. Burt,et al.  Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. , 2015, Journal of hepatology.

[7]  Mats Fredrikson,et al.  Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up , 2015, Hepatology.

[8]  A. McCullough,et al.  Age Impacts Ability of Aspartate–Alanine Aminotransferase Ratio to Predict Advanced Fibrosis in Nonalcoholic Fatty Liver Disease , 2015, Digestive Diseases and Sciences.

[9]  M. Bellis,et al.  Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis , 2014, The Lancet.

[10]  M. Yeh,et al.  Pathological features of fatty liver disease. , 2014, Gastroenterology.

[11]  G. Bedogni,et al.  Epidemiology of fatty liver: an update. , 2014, World journal of gastroenterology.

[12]  P. Noris,et al.  Platelet count and aging , 2014, Haematologica.

[13]  A. Burt,et al.  Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease. , 2014, Journal of hepatology.

[14]  Q. Anstee,et al.  Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging , 2013, Frontline Gastroenterology.

[15]  B. Neuschwander‐Tetri,et al.  Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients , 2013, Hepatology.

[16]  U. Drebber,et al.  Stepwise Combination of Simple Noninvasive Fibrosis Scoring Systems Increases Diagnostic Accuracy in Nonalcoholic Fatty Liver Disease , 2013, Journal of clinical gastroenterology.

[17]  P. Bedossa,et al.  A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver. , 2013, Journal of hepatology.

[18]  Q. Anstee,et al.  Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification , 2013, Journal of Clinical Pathology.

[19]  A. Burt,et al.  Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels? , 2013, European journal of gastroenterology & hepatology.

[20]  G. Targher,et al.  Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis , 2013, Nature Reviews Gastroenterology &Hepatology.

[21]  H. Cortez‐Pinto,et al.  Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal. , 2013, Journal of hepatology.

[22]  N. Chavez-Tapia,et al.  Validation study of systems for noninvasive diagnosis of fibrosis in nonalcoholic fatty liver disease in Latin population. , 2013, Annals of hepatology.

[23]  Jun-Ping Shi,et al.  Suboptimal performance of simple noninvasive tests for advanced fibrosis in Chinese patients with nonalcoholic fatty liver disease , 2012, Journal of digestive diseases.

[24]  E. van Marck,et al.  Noninvasive assessment of nonalcoholic fatty liver disease in obese or overweight patients. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[25]  K. Cusi,et al.  Corrigendum:The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association , 2012, The American Journal of Gastroenterology.

[26]  K. Cusi,et al.  The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association , 2012, The American Journal of Gastroenterology.

[27]  W. Gedroyc,et al.  Quantifying hepatic steatosis – more than meets the eye , 2012, Histopathology.

[28]  A. Pollett,et al.  Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe. , 2012, Journal of hepatology.

[29]  D. Brenner,et al.  Serum levels of alanine aminotransferase decrease with age in longitudinal analysis. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[30]  Giorgio Saracco,et al.  The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study , 2011, Hepatology.

[31]  M. Bulsara,et al.  Complex non‐invasive fibrosis models are more accurate than simple models in non‐alcoholic fatty liver disease , 2011, Journal of gastroenterology and hepatology.

[32]  T. Schiano,et al.  Increasing hepatic arteriole wall thickness and decreased luminal diameter occur with increasing age in normal livers. , 2011, Journal of hepatology.

[33]  Q. Anstee,et al.  How big a problem is non-alcoholic fatty liver disease? , 2011, BMJ : British Medical Journal.

[34]  V. Basevi.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[35]  E. Barrett-Connor,et al.  Alanine Aminotransferase Decreases with Age: The Rancho Bernardo Study , 2010, PloS one.

[36]  A. Burt,et al.  Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease , 2022 .

[37]  Chris Day,et al.  A position statement on NAFLD/NASH based on the EASL 2009 special conference. , 2010, Journal of hepatology.

[38]  Vincent Wai-Sun Wong,et al.  Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years , 2010, Gut.

[39]  V. de Lédinghen,et al.  Pitfalls of liver stiffness measurement: A 5‐year prospective study of 13,369 examinations , 2010, Hepatology.

[40]  Julien Vergniol,et al.  Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease , 2010, Hepatology.

[41]  A. Sanyal,et al.  Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[42]  I. Guha,et al.  Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers , 2007, Hepatology.

[43]  S. Pol,et al.  FIB‐4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest , 2007, Hepatology.

[44]  T. Therneau,et al.  The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD , 2007, Hepatology.

[45]  M. Holmqvist,et al.  Long‐term follow‐up of patients with NAFLD and elevated liver enzymes , 2006, Hepatology.

[46]  J. Montaner,et al.  Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection , 2006, Hepatology.

[47]  V. de Lédinghen,et al.  Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease , 2006, BMC gastroenterology.

[48]  P. Giral,et al.  Sampling variability of liver biopsy in nonalcoholic fatty liver disease. , 2005, Gastroenterology.

[49]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[50]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[51]  D. L. Le Couteur,et al.  Age‐related pseudocapillarization of the human liver , 2003, The Journal of pathology.

[52]  E. Schiff,et al.  Liver disease in the elderly. , 2001, Gastroenterology clinics of North America.

[53]  J. Hoofnagle,et al.  Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. , 1988, Gastroenterology.